Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

Presentation TCT 2019

Critical Analysis of De Novo and ISR Clinical Trial Data

Presenter: Fernando Alfonso

September 28, 2019

Presentation TCT 2019

Assessment and Treatment of ISR and Stent Thrombosis Lesions Using Intravascular Imaging (Including Neoatherosclerosis)

Presenter: Christos Bourantas

September 27, 2019

Presentation TCT 2019

Flash Debate: Repeat DES Is Most Effective Treatment for ISR and Should Be the Preferred Option!

Presenter: Jose Henriques

September 27, 2019

Presentation TCT 2019

Flash Debate: Drug-Coated Balloons Are the Best Treatment for ISR and Avoids Further Stent Layers!

Presenter: Paul Ong

September 27, 2019

Presentation TCT 2019

Case #8: ISR — Make a Guess or Get Informed by OCT

Presenter: Stuart Watkins

September 26, 2019

Presentation TCT 2019

Case #7: Vein Graft ISR — Findings by OCT

Presenter: Mette Charlot

September 26, 2019

Presentation TCT 2019

Case #6: I Used OCT in This Calcified ISR

Presenter: Peep Laanmets

September 26, 2019

Presentation TCT 2019

Case #5: Unexpected Mechanism of ISR Revealed by OCT

Presenter: Marc Feldman

September 26, 2019

Presentation TCT 2019

Case #4: OCT-Guided Laser Therapy in ISR

Presenter: Peter O'Kane

September 26, 2019

Presentation TCT 2019

Case #3: Same Strategy With or Without OCT in ISR?

Presenter: Colm Hanratty

September 26, 2019

Presentation TCT 2019

Case #2: ISR Requires Stepwise OCT-Guiding

Presenter: Jacob Odenstedt

September 26, 2019

Presentation TCT 2019

Case #1: OCT Guided Lesion Preparation in ISR

Presenter: Indulis Kumsars

September 26, 2019

Presentation TCT 2019

First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results

Presenter: Alexandre Abizaid

September 26, 2019

TCT Shark Tank Innovation Competition Finalists - Renal Vein Pressure Decompression for Advanced Decompensated Heart Failure (Magenta Medical)

Presentation TCT 2019

Renal Vein Pressure Decompression for Advanced Decompensated Heart Failure (Magenta Medical)

Presenter: David Israeli

September 26, 2019

Presentation TCT 2019

Current DCBs: Challenges of Paclitaxel and the Downsides of Coatings

Presenter: Robert Byrne

September 26, 2019

Presentation TCT 2019

Virtue® SEB: Promising Data for Innovative LIMUS Delivery

Presenter: Juan Granada

September 26, 2019

Presentation TCT 2019

Potential Hazards of Re-Stenting

Presenter: David Kandzari

September 26, 2019

Advertisement

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Critical Analysis of De Novo and ISR Clinical Trial Data

Assessment and Treatment of ISR and Stent Thrombosis Lesions Using Intravascular Imaging (Including Neoatherosclerosis)

Flash Debate: Repeat DES Is Most Effective Treatment for ISR and Should Be the Preferred Option!

Flash Debate: Drug-Coated Balloons Are the Best Treatment for ISR and Avoids Further Stent Layers!

Case #8: ISR — Make a Guess or Get Informed by OCT

Case #7: Vein Graft ISR — Findings by OCT

Case #6: I Used OCT in This Calcified ISR

Case #5: Unexpected Mechanism of ISR Revealed by OCT

Case #4: OCT-Guided Laser Therapy in ISR

Case #3: Same Strategy With or Without OCT in ISR?

Case #2: ISR Requires Stepwise OCT-Guiding

Case #1: OCT Guided Lesion Preparation in ISR

First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results

Renal Vein Pressure Decompression for Advanced Decompensated Heart Failure (Magenta Medical)

Current DCBs: Challenges of Paclitaxel and the Downsides of Coatings

Virtue® SEB: Promising Data for Innovative LIMUS Delivery

Potential Hazards of Re-Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content